AMRI Announces Five-Year Extension of API Supply Agreement with Shire
News Oct 23, 2012
AMRI has announced that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc, is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine.
The agreement extends a previously existing agreement between the two companies. The terms of the agreement are confidential.
“We are pleased to extend this agreement with Shire,” said Thomas E. D’Ambra, Ph.D., Chairman, President and Chief Executive Officer of AMRI.
D’Ambra continued, “Our partnership lays the groundwork for AMRI to be considered by Shire for future development and manufacturing opportunities.”
3rd International Conference and Exhibition on Nanomedicine and Drug Delivery
Mar 13 - Mar 14, 2019